Common Contracts
7 similar Securities Purchase Agreement contracts by Givemepower Corp, Arrowhead Pharmaceuticals, Inc., Herschkowitz Samuel, others
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 19th, 2021 • Givemepower Corp • Real estate • California
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of October 20, 2020 by and among GiveMePower Corporation, a Nevada corporation (the “Company”), and the purchaser, Poverty Solutions, Inc. (“Purchaser”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 21st, 2020 • Givemepower Corp • Real estate • California
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of October 20, 2020 by and among GiveMePower Corporation, a Nevada corporation (the “Company”), and the purchaser, Poverty Solutions, Inc. (“Purchaser”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 23rd, 2019 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of September 20, 2019 (the “Effective Date”) by and among HTG Molecular Diagnostics, Inc., a Delaware corporation (the “Company”), and each of those persons and entities, severally and not jointly, listed as a Purchaser on the Schedule of Purchasers attached as Schedule I hereto (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 10th, 2016 • Arrowhead Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of August 8, 2016 (the “Effective Date”) by and among Arrowhead Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of those persons and entities, severally and not jointly, listed as a Purchaser on the Schedule of Purchasers attached as Schedule I hereto (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 9th, 2015 • Herschkowitz Samuel • Orthopedic, prosthetic & surgical appliances & supplies • New York
This SECURITIES PURCHASE AGREEMENT, including additional securities purchase agreement that may be executed pursuant to which preferred shares will be purchased (each such closing referred to herein as this “Agreement”) is made and entered into as of February 4, 2014 by and among Skyline Medical Inc., a Delaware corporation (the “Company”), and the purchasers listed on Schedule I hereto (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 5th, 2014 • Skyline Medical Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
This SECURITIES PURCHASE AGREEMENT, including additional securities purchase agreement that may be executed pursuant to which preferred shares will be purchased (each such closing referred to herein as this “Agreement”) is made and entered into as of February 4, 2014 by and among Skyline Medical Inc., a Delaware corporation (the “Company”), and the purchasers listed on Schedule I hereto (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 7th, 2013 • RXi Pharmaceuticals Corp • Pharmaceutical preparations • Delaware
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of March 6, 2013 by and among RXi Pharmaceuticals Corporation, a Delaware corporation (the “Company”), and the purchasers listed on Schedule I hereto (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.
